These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators. Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119 [TBL] [Abstract][Full Text] [Related]
14. SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists. Terefenko EA; Kern J; Fensome A; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P Bioorg Med Chem Lett; 2005 Aug; 15(15):3600-3. PubMed ID: 15978807 [TBL] [Abstract][Full Text] [Related]
15. Insight from molecular modeling into different conformation and SAR of natural steroids and unnatural 7-oxa-steroids. Kang FA; Chen X; Jain N; Allan G; Tannenbaum P; Lundeen S; Sui Z Bioorg Med Chem Lett; 2008 Jul; 18(13):3687-90. PubMed ID: 18539027 [TBL] [Abstract][Full Text] [Related]
16. Copper-catalyzed cyclization of steroidal acylaminoacetylenes: syntheses of novel 11beta-aryl-17,17- spiro[(4'H,5'-methylene)oxazol]-substituted steroids. Jin C; Burgess JP; Kepler JA; Cook CE Org Lett; 2007 May; 9(10):1887-90. PubMed ID: 17439133 [TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton. Nakagawa A; Uno S; Makishima M; Miyachi H; Hashimoto Y Bioorg Med Chem; 2008 Jul; 16(14):7046-54. PubMed ID: 18586498 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist. Jiang W; Fiordeliso JJ; Allan G; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z Bioorg Med Chem Lett; 2007 Mar; 17(5):1471-4. PubMed ID: 17258455 [TBL] [Abstract][Full Text] [Related]
19. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence. Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484 [TBL] [Abstract][Full Text] [Related]
20. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents. Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]